Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Akeso, Henlius, Imugene, Kexing, Transthera.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Daiichi Sankyo, Innocare, Ractigen, Samsung Bioepis, Yoltech.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Antengene, Asieris, Innovent, Otsuka, Senhwa, Shaperon, Sosei.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bioarctic AB, Immunlabs, Imugene, Recce, Remegen, Takeda.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Beigene, Innovent, Pharmaust, Recce.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: CASI, Cellitrion, Everest, Innovent, Kazia, Mabwell, Neurophth, Simcare.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Hutchmed, Iregene, Kyowa Kirin, Olix, Opthea, Otsuka, Takeda.